Inhibition of sickling by methyl acetimidate  by Chao, Tessa L. et al.
Volume 62, number 1 FEBS LETFERS February 1976 
INHIB IT ION OF S ICKL ING BY METHYL  ACET IMIDATE 
Tessa L. CHAO, Marion R. BERENFELD and Thomas G. GABUZDA 
Department of  Hematology, Division of  Research, Lankenau Hospital, and The Cardeza Foundation, 
Jefferson Medical College Philadelphia, Pa. 19151, USA 
Received 24 November 1975 
1. Introduction 
A computer generated model recently proposed 
for the alignment of hemoglobin S molecules in the 
microtubules which form within deoxygenated 
sickled cells, has implicated several Lys side chains 
in the intermolecular contact regions [1 ]. If this 
aspect of the model is correct, chemical modification 
of these amino groups would be expected to inhibit 
sickling. Imidoesters would appear to be appropriate 
reagents for this purpose since they have been shown 
to react selectively with protein amino groups [2,3]. 
MAI* was employed for the initial in vitro studies 
because: (1) modification of protein amino groups 
reportedly does not alter the charge of the protein at 
physiological pH [4] ; (2) reaction of hemoglobin A 
with MAI does not appreciably affect co-operativity 
or the Bohr effect [5] ; (3) DMA, a bifunctional 
imidoester, has been shown to inhibit sickling [6] ; (4) 
MAI is the smallest imidoester and therefore should 
introduce less steric obstruction than any other 
imidoester. 
2. Materials and methods 
Fresh heparinized blood was obtained from sickle 
cell anemia patients. The amount of hemoglobin F, 
determined by the alkali denaturation method [7], 
* Abbreviations: MAI, methyl acetimidate; DMA, dimethyl 
adipimidate; MGC, minimum deoxygenated hemoglobin 
concentration required for gelation. 
was less than 4%. Erythrocytes were washed with 
Krebs-Henseleit buffer, pH 7.4, containing 200 mg/ 
100 ml glucose, and were resuspended to a final 
hematocrit of 20%. One vol of the erythrocyte sus- 
pension was diluted with four vols of 0.14 M Tris- 
HC1 buffer, pH 8.8. Equal vols of this suspension 
were added to flasks containing appropriate amounts 
of DMA or MAI (Pierce Chemical Co.). Control 
samples were prepared and treated in an identical 
manner, omitting the imidoesters. The solutions 
were incubated for 20 min at room temperature and 
then washed with Krebs-Henseleit buffer to lower 
the pH. A small portion of the washed cells was 
resuspended to a hematocrit of 40%, divided into 
aliquots and equilibrated with either water-saturated 
5% CO2-95% N2 or 5% CO2-95% air gas mixtures 
for 1.5 h. The gas equilibrated solutions were trans- 
ferred anaerobically into 10% (v/v) HCHO in 0.9% 
saline for fixation. The percentage of sickled cells 
in a total of 500 cells was determined. The main 
portion of the incubated cell suspension was lysed 
according to the method of Drabkin [8], and dia- 
lyzed overnight at 4°C against O. 15 M potassium 
phosphate buffer, pH 7.35. Lysate obtained from 
treated erythrocytes was subjected to starch gel 
electrophoresis [9], gel filtration on Ultrogel AcA 44 
(LKB), and the MGC of each treated sample was 
determined in triplicate and expressed as the range in 
values, according to the method of Bookchin et al. 
[ 10]. The dialyzed samples were concentrated by 
centrifugation through Centriflo membrane cones 
(Amicon). The percentage of methemoglobin was 
determined spectrophotometrically [ 11 ]. 
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3. Results 
Incubation of sickle cell anemia erythrocytes with 
increasing concentrations of MAI resulted in a pro- 
gressive decrease in the number of sickled cells both 
after complete deoxygenation (table 1) and in the 
presence of air (table 2). 
An increase in MGC was observed in lysate obtained 
from the MAI treated erythrocytes. The MGC of dia- 
lyzed lysate obtained from untreated erythrocytes was 
26.1 -+ 0.4 gm%, and increased to 28.6 -+ 0.4 gm% and 
34.5 -+ 0.2 gm% after the cells were incubated with 
5 and 10 mM MAI, respectively. Since the methemo- 
globin level in these cells was below 1%, there is no 
question that the antisickling effect of MAI was due 
to chemical modification of the hemoglobin. The 
MGC value of erythrocytes treated with 5 mM DMA 
could not be determined because these cells could not 
be lysed even when four volumes of water and one 
volume of toluene per volume of packed cells was 
used. The small amount of hemoglobin that was 
obtained formed a gel upon standing in the presence 
of oxygen. Similar results have been reported for 
DMA treated normal human erythrocytes [ 12] 
Gel filtration of lysate obtained from MAI incu- 
bated erythrocytes ( ickle as well as normal) on 
Ultrogel AcA 44 (1.2 × 86 cm) in 0.15 M potassium 
Table 1 
Effect of imidoesters on erythrocyte sickling 
upon complete deoxygenation 
Imidoester % Sickled cells 
None 91.0 
5 mM DMA 5.3 
5 mM MAI 5.0 
10 mM MAI 3.0 
For reaction conditions see Materials and methods. 
Table 2 
Effect of imidoesters on irreversibly sickled cells 
Imidoester % Sickled cells 
None 5.8 
5 mM DMA 4.2 
5 mM MAI 2.7 
10 mM MAI 1.5 
58 
Table 3 
Proportion of high mol. wt. hemoglobin S components 
as a function of MAI concentration a 
MAI (mM) % High mol. wt. HbS 
1.25 14.6 
2.5 18.4 
5.0 22.6 
10.0 26.9 
a Dialyzed lysate obtained from MAI incubated sickle cell 
anemia erythrocytes was gel f'lltered on an Ultrogel AcA 44 
column (1.2 × 86 cm) equilibrated with 0.15 M potassium 
phosphate, pH 7.35. 
phosphate at pH 7.35, flow rate 0.6 ml/min, revealed 
the presence of hemoglobin components eluting 
ahead of normal hemoglobin i  the void volume of 
the column. The amount of high mol. wt. material 
varied as a function of the MAI concentration used 
in the incubation (table 3). 
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Fig.1. Starch gel electrophoresis in Tris-borate-EDTA buffer, 
pH 8.6, of lysate obtained from erythrocytes treated with 
MAI; stained with amido black. Erythrocytes obtained from 
sickle cell anemia patients were treated with: (a) and (f) 0 
(Control), (b) l0 mM, (c) 5.0 mM, (d) 2.5 mM, and (e) 
1.25 mM, MAI. 
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Starch gel electrophoresis with Tris-borate-EDTA 
buffer, pH 8.6, of lysate obtained from the MAI 
treated erythrocytes showed components moving 
both more rapidly and more slowly toward the anode 
than the principal component (fig.l). The chemical 
nature of the components with altered charge has not 
been determined. Starch gel electrophoresis of the 
high mol. wt. material obtained after gel filtration 
showed it to be the slow moving components. 
4. Discussion 
MAI has been shown to inhibit sickling of sickle 
cell anemia erythrocytes after complete deoxygena- 
tion. The number of irreversibly sickled cells was 
also decreased. Although the molecular basis for this 
inhibition has not yet been established, reaction of 
hemoglobin A with MAI at a higher hemoglobin: MAI 
molar ratio (1 : 10) has been shown [5] to modify 1% 
of the valyl N-terminal residues and 3% of lysyl 
residues in the ct chain, and 3% of the N-terminal 
valyl residues and 14% of the lysyl residues in the 13 
chain. The oxygen affinity of the modified hemo- 
globin A was increased, but a change in oxygen 
affinity cannot account entirely for the decrease in 
sickling reported here, since the effect was observed 
in the absence of oxygen. The inhibition of sickling 
possibly is due to destabilization of the deoxyhemo- 
globin S aggregate caused by modification of Lys 
residues involved in the intermolecular contact 
regions, and/or to modification of the N-terminal 
amino groups. 
DMA also has been shown to inhibit sickling after 
complete deoxygenation f treated erythrocytes, and 
high mol. wt. components were observed as a function 
of DMA concentration [6]. Contrary to previous 
results on proteins treated with monofunctional 
imidoesters at low protein concentrations [2,4,13] 
high mol. wt. components were also observed in the 
MAI treated erythrocytes. However, reaction of 
4.97 mM hemoglobin S lysate with 9.35 mM MAI 
after dialysis against 0.14 M Tris-HC1 buffer, pH 8.8 
at 4°C overnight, gave only 1.2% high mol. wt. com- 
ponents. Apparently, formation of high mol. wt. 
hemoglobin components is dependent upon particular 
conditions found in the red cell. The relationship 
between the high molecular weight components and 
the antisickling effect of MAI is yet to be determined. 
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